Literature DB >> 11745943

Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally.

P Ondoa1, D Davis, B Willems, L Heyndrickx, L Kestens, I van der Berg, S Coppens, W Janssens, J Heeney, G van der Groen.   

Abstract

Specific neutralizing epitope changes have been observed in a chimpanzee infected naturally with SIVcpz, which differ from HIV-1 infecting humans. To characterize further these changes, a longitudinal study of env genomic sequence variation of SIVcpz-ant isolates was undertaken in this animal. The V1 and V2 regions of the env were determined to arise from specific recombination events. To determine whether recombination of the V1 and V2 domains was possibly associated with the emergence of neutralization escape viruses, envelope sequences and gene length polymorphisms from PBMC and plasma viral variants were studied over a 7-year period. PBMCs and plasma-associated infectious virus titers as well as plasma RNA viral loads were monitored longitudinally. The first 5 viruses isolated from the plasma were found to be neutralization escape variants. Sequence analysis of their V1 and the V2 regions indicated that a 20 amino acid stretch of the V1 region had undergone recombination and was also associated with the emergence of isolates eliciting strong neutralization responses. These findings support the hypothesis that recombination of the V1 and V2 regions of the envelope play a role in neutralization escape of SIVcpz in chimpanzees infected naturally. Furthermore, the data confirm that the neutralizing antibody response plays an important role in the decline of plasma infectious virus titers in HIV-1 related SIVcpz nonpathogenic infection. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745943     DOI: 10.1002/jmv.2102

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Transmission of simian immunodeficiency virus SIVcpz and the evolution of infection in the presence and absence of concurrent human immunodeficiency virus type 1 infection in chimpanzees.

Authors:  Jonathan L Heeney; Erik Rutjens; Ernst J Verschoor; Henk Niphuis; Peter ten Haaft; Scott Rouse; Hazel McClure; Sunita Balla-Jhagjhoorsingh; Willy Bogers; Mary Salas; Kathy Cobb; Luc Kestens; David Davis; Guido van der Groen; Valerie Courgnaud; Martine Peeters; Krishna K Murthy
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Noninvasive follow-up of simian immunodeficiency virus infection in wild-living nonhabituated western lowland gorillas in Cameroon.

Authors:  Lucie Etienne; Sabrina Locatelli; Ahidjo Ayouba; Amandine Esteban; Christelle Butel; Florian Liegeois; Avelin Aghokeng; Eric Delaporte; Eitel Mpoudi Ngole; Martine Peeters
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

3.  Single real-time reverse transcription-PCR assay for detection and quantification of genetically diverse HIV-1, SIVcpz, and SIVgor strains.

Authors:  Lucie Etienne; Sabrina Eymard-Duvernay; Avelin Aghokeng; Christelle Butel; Marjorie Monleau; Martine Peeters
Journal:  J Clin Microbiol       Date:  2012-12-19       Impact factor: 5.948

4.  Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms.

Authors:  Lucie Etienne; Eric Nerrienet; Matthew LeBreton; Godwin Tafon Bibila; Yacouba Foupouapouognigni; Dominique Rousset; Ahmadou Nana; Cyrille F Djoko; Ubald Tamoufe; Avelin F Aghokeng; Eitel Mpoudi-Ngole; Eric Delaporte; Martine Peeters; Nathan D Wolfe; Ahidjo Ayouba
Journal:  Retrovirology       Date:  2011-01-13       Impact factor: 4.602

5.  Evolution of the uniquely adaptable lentiviral envelope in a natural reservoir host.

Authors:  L J Demma; T H Vanderford; J M Logsdon; M B Feinberg; S I Staprans
Journal:  Retrovirology       Date:  2006-03-20       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.